United Kingdom - English - myHealthbox

gp-pharm, s.a - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5mg - hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.

Ireland - English - HPRA (Health Products Regulatory Authority)

gp-pharm, s.a. - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

Ireland - English - HPRA (Health Products Regulatory Authority)

gp-pharm, s.a. - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

Malta - English - Medicines Authority

mint health ltd 3/4, cantrija complex, triq it-targa, il-maghtab naxxar. nxr6613, malta - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - leuprorelin acetate 3.75 mg - endocrine therapy

Ireland - English - HPRA (Health Products Regulatory Authority)

gp-pharm, s.a. - leuprorelin acetate - pdr+solv for pr for susp for inj - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.

Ireland - English - HPRA (Health Products Regulatory Authority)

gp-pharm, s.a. - leuprorelin acetate - pdr+solv for pr for susp for inj - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - leuprorelin acetate - powder and solvent for suspension for injection - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of locally advanced or metastatic prostate cancer

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - leuprorelin acetate - powder and solvent for suspension for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - it t is indicated for palliative treatment of hormone dependent advanced prostate cancer

United Kingdom - English - myHealthbox

mercury pharmaceuticals limited - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 3.75 mg - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - lutrate 1 month depot is indicated for palliative treatment of locally advanced or metastatic prostate cancer.

United Kingdom - English - myHealthbox

mercury pharmaceuticals limited - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection. - 22.5 mg - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - lutrate 3 month depot is indicated for palliative treatment of hormone dependent advanced prostate cancer.